Clinical efficacy and safety of nivolumab in malignant non-pleural mesothelioma: a multicenter, open-label, single-arm, Japanese phase II trial (Viola) protocol(原著論文等 (英文))
Kuribayashi K, Igeta M, Daimon T, Ibu M, Suna S, Okamoto R, Kijima T. Clinical efficacy and safety of nivolumab in malignant non-pleural mesothelioma: a multicenter, open-label, single-arm, Japanese phase II trial (Viola) protocol. Oncology. 2023;101(4):257-261.